Last €61.83 EUR
Change Today +0.55 / 0.90%
Volume 3.7K
BOI On Other Exchanges
Symbol
Exchange
EN Paris
OTC US
Frankfurt
As of 11:35 AM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

boiron sa (BOI) Snapshot

Open
€61.35
Previous Close
€61.28
Day High
€62.50
Day Low
€61.28
52 Week High
06/2/14 - €68.39
52 Week Low
08/21/13 - €39.01
Market Cap
1.2B
Average Volume 10 Days
5.3K
EPS TTM
€4.24
Shares Outstanding
19.4M
EX-Date
06/3/14
P/E TM
14.6x
Dividend
€1.20
Dividend Yield
1.94%
Current Stock Chart for BOIRON SA (BOI)

Related News

No related news articles were found.

boiron sa (BOI) Related Businessweek News

No Related Businessweek News Found

boiron sa (BOI) Details

Boiron SA, a pharmaceutical company, together with its subsidiaries, manufactures and sells nonproprietary homeopathic medicines and OTC medication specialties. It offers homeopathic medicines in two family groups, including medicines associated with precise therapeutic indications and dosage in the form of tablets, syrups, creams, and single-dose liquids; and medicines that do not mention a therapeutic indication or dosage in the form of tubes, granular tubes, and cellular doses. The company produces its medicines by using vegetable, animal, and mineral substances. It primarily operates in France, rest of Europe, and North America. Boiron SA was founded in 1932 and is headquartered in Messimy, France.

3,007 Employees
Last Reported Date: 04/7/14
Founded in 1932

boiron sa (BOI) Top Compensated Officers

Chief Pharmacist, Director of Production & Di...
Total Annual Compensation: €496.0K
General Manager and Director
Total Annual Compensation: €896.5K
Compensation as of Fiscal Year 2013.

boiron sa (BOI) Key Developments

Boiron SA Reports Unaudited Sales Results for the Second Quarter Ended June 2014; Provides Earnings Guidance for the First Half of 2014

Boiron SA reported unaudited sales results for the second quarter ended June 2014. For the quarter, the group total sales were €121,407,000 against €117,763,000 a year ago. Sales in the second quarter of 2014 increased by 3.1% compared to the second quarter of 2013. The company provided earnings guidance for the first half of 2014. Income in the first half of 2014 should be lower than the first half of 2013 which benefited from exceptionally high business volume.

Boiron SA Announces Unaudited Sales Results for the First Quarter Ended March 31, 2014

Boiron SA announced unaudited sales results for the first quarter ended March 31, 2014. For the quarter, the company reported group total sales for the first quarter of 2014 is decreasing by 11.3% to EUR 158,021,000 compared to the sales for the first quarter of 2013 of EUR 140,209,000, which was highlighted by a high level of worldwide pathology.

Boiron Announces Resignation of Philippe Montant from His Functions of Deputy General Manager

Boiron announced that Philippe Montant has resigned from his functions of Deputy General Manager.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BOI:FP €61.83 EUR +0.55

BOI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BOI.
View Industry Companies
 

Industry Analysis

BOI

Industry Average

Valuation BOI Industry Range
Price/Earnings 14.2x
Price/Sales 1.9x
Price/Book 3.0x
Price/Cash Flow 14.2x
TEV/Sales 1.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BOIRON SA, please visit www.boiron.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.